Avertix Medical

Avertix Medical is a leader in advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease. Through a commitment to innovation, rigorous clinical science, and collaborative partnerships, Avertix Medical is dedicated to providing cutting-edge solutions for the medical community. Avertix Medical's FDA-approved labeling for the Guardian System underscores its commitment to safety and effectiveness, ensuring physicians, health systems, and allied health professionals have access to advanced tools to elevate patient care standards.

The Avertix Guardian™ system represents a significant breakthrough as the first implantable, patient-alerting technology designed to promptly warn individuals to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. By addressing the critical issue of delays in treatment, Avertix Medical aims to significantly reduce mortality and morbidity associated with heart attacks. The Guardian system offers a proactive approach, especially crucial considering the unreliability of traditional symptoms in predicting ACS events.

Avertix Medical is headquartered at 40 Christopher Way, Eatontown, New Jersey 07724, US. We invite the management team at Avertix Medical to enhance your company’s presence on our platform by creating a customized and exclusive company showcase and detailed product listings, ensuring your innovative solutions reach a wider audience.